HAIKOU, China, June 15, 2024 /PRNewswire/ — A report from Hainan International Media Center: Recently, a delegation from China’s southern Hainan Province visited South Korea and the United States for economic, trade and cultural exchange activities. By promoting the policies of the Hainan Free Trade Port (FTP) and displaying the high-quality development results, Hainan has deepened […]
Category Archives: Pr Newswire
SHANGHAI, June 15, 2024 /PRNewswire/ — Seeing the world’s first IEC TS 63126:2020 (2 PfG 2971) photovoltaic module certificate, the world’s first IEC TS 63126 PV junction box certificate and the world’s first IEC TS 63126 PV module connector certificate granted by TÜV Rheinland to multiple solar module products of Astronergy’s ASTRO N series at SNEC […]
ZHOUSHAN, China, June 14, 2024 /PRNewswire/ — This summer, the 4th Zhejiang Ocean Games were grandly held on the picturesque island of Shengsi, attracting over 7,000 marine sports enthusiasts from across the country. Spanning from May to June, this month-long competition has significantly boosted attention towards Zhejiang’s burgeoning marine economy and island tourism. Shengsi Hosts […]
BEIJING, June 15, 2024 /PRNewswire/ — A Report from People’s Daily: The Ukraine crisis has shown no sign of stopping and generated more spillovers. The conflict could further escalate. The pressing priority is to cool down the situation and accumulate conditions for ceasefire. China did not create the Ukraine crisis, nor is it a party […]
WUHAN, China, June 15, 2024 /PRNewswire/ — On June 6, Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), in collaboration with China Mobile, unveiled the world’s first 800G hollow-core fibre transmission test network in Shenzhen–Dongguan, Guangdong. The development is a significant milestone in the evolution of telecommunications infrastructure, pushing the boundaries of traditional fibre […]
Pr Newswire
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance
15
Jun
Jun
MINNEAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), reports that it has received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards (the “Delinquency Notification”) due to an […]
15
Jun
Jun
SAN MATEO, Calif. and SINGAPORE, June 14, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (“ASLAN” or the “Company”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it plans to change the ratio of the American Depositary Shares (“ADSs”) to its ordinary shares, par value $0.01 […]
15
Jun
Jun
SAN FRANCISCO, June 14, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock […]
Pr Newswire
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
15
Jun
Jun
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual European Hematology Association (EHA) 2024 Hybrid Congress. Galapagos’ product candidate GLPG5101 is […]
Pr Newswire
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
15
Jun
Jun
The Phase 3 study results are being published in PAIN® Journal, which is the leading journal devoted to pain medicine and research. PAIN is the official journal of the International Association for the Study of Pain, and features original research on the nature, mechanisms and treatment of pain. This Phase 3 study met primary and […]